Open Access

An immunocompetent migrant presenting with neurosyphilis with an unusual unilateral papillitis: a case report

  • Paolo Turchetti1,
  • Fernanda Pacella2,
  • Elena Pacella2,
  • Concetta Mirisola1 and
  • Ilaria Uccella1Email author
European Journal of Medical Research201217:3

https://doi.org/10.1186/2047-783X-17-3

Received: 16 December 2011

Accepted: 14 February 2012

Published: 14 February 2012

Abstract

Unilateral papillitis caused by Treponema pallidum was found in an immunocompetent homosexual patient with severe vision loss who had received previous antibiotics treatment. Syphilis-related ocular manifestation is more common in the early stages of the disease and it can be associated with a central nervous system localization. In this patient, neurosyphilis was diagnosed on the basis of clinical and laboratory findings. Optical examination revealed unilateral papillitis in the left eye and no relative afferent pupillary defects. The patient underwent visual field examinations with conventional perimetry using the 30-2 program of the Humphrey Visual Field Analyzer, which indicated a blind spot enlargement in the left eye. Optical coherence tomography, visual evoked potentials (VEP), and fluorescein angiograms revealed inflammation of the optic nerve head with edematous and blurred margins. A reactive T. pallidum hemagglutination assay with low rapid plasma reagin (RPR) serum titer was performed; an HIV antibody test and MRI of the orbits and head with contrast gave negative results. Resolution of the ocular inflammation after intravenous penicillin treatment was obtained. The reported case illustrates the importance of early recognition of this treatable disease. The rise of syphilis, especially in urban areas, necessitates a high level of suspicion when dealing with patients with intraocular inflammation of unknown origin. Lues serology should be incorporated into routine laboratory diagnostics to aid in the detection of such cases. Considering the re-emergence of syphilis, screening of migrants from countries with high syphilis seroprevalences should be recommended.

Keywords

migrant papillitis syphilis treponema

Introduction

Syphilis represents a global health issue, with an estimated 12 million people infected every year; this infectious disease is prevalent in Africa, Asia and South America. In European countries, syphilis is considered a re-emerging infectious pathology. The European Centre for Disease Prevention and Control (ECDC) has reported that the overall number of syphilis cases increased substantially in most Western European countries between 1998 and 2007, mostly among men [1].

In recent years, most of the reported syphilis cases have been associated with HIV infection [25].

In 2007, Italy registered 720 cases of syphilis, 561 among males. No data exist about migrants. The complexity of syphilis diagnosis based on clinical and serological findings is already subject of scientific discussion, and is leading to the revision of treatment guidelines [6, 7].

Severe vision loss due to Treponema pallidum causing syphilis is a rare manifestation of this disease in the antibiotic era, especially in developed countries [8, 9]. The most common ocular manifestation of this infection is uveitis, occurring in 2.5 to 5% of patients with tertiary syphilis [10]. Other ocular manifestations are focal retinitis, papillitis, iritis, keratic precipitates, periphlebitis, vitritis, and serous and exudative retinal detachment [11, 12].

The ability of syphilis to mimic different ocular disorders can lead to misdiagnosis and delay in the administration of appropriate antimicrobial therapy, particularly in persons who receive inadequate penicillin therapy. To the best of our knowledge, few cases of unusual neurosyphilis presentation have been reported in the literature. In the present work, a case of ocular and atypical neurosyphilis in an HIV-negative patient is described.

Case report

A 38-year-old Brazilian transgender patient attending the outpatient department of the National Institute for Health, Migration and Poverty (NIHMP), presented with a sudden decrease of visual acuity in the left eye (visual best-corrected acuity (VBCA) 20/70). The patient's history revealed a previous treatment with antibiotics for a dental infection. The last event of unprotected sexual intercourse dated back to 1 year previously.

An optical examination revealed unilateral papillitis in left eye (Figure 1) and no relative afferent pupillary defect (RAPD). The patient underwent visual field examinations with conventional perimetry using the 30-2 program of the Humphrey Visual Field Analyzer that indicated a slight central sensitivity loss or a paracentral scotoma in the left eye (Figures 2 and 3).
Figure 1

Fundus appearance of the left eye at initial presentation.

Figure 2

The 30-2 program of the Humphrey Visual Field Analyzer that indicates a slight central sensitivity loss or a paracentral scotoma in the left eye (see also Figure 3).

Figure 3

The 30-2 program of the Humphrey Visual Field Analyzer that indicates a slight central sensitivity loss or a paracentral scotoma in the left eye (see also Figure 2).

An optical coherence tomography (OCT) scan of the left eye showed some thickening of the retinal pigment epithelium (RPE) layer at initial presentation (Figure 4). The visual evoked potentials (VEPs) revealed a decrease in VEP amplitude with normal latency (Figure 5). Fluorescein angiograms (FA) (Figure 6A, B) revealed inflammation of the optic nerve head with edematous and blurred margins.
Figure 4

Optical coherence tomography (OCT) scan of the left eye at initial presentation. There was some thickening of the retinal pigment epithelium (RPE) layer with the inflammation of the optic nerve head with edematous and blurred margins.

Figure 5

The visual evoked potentials (VEP) revealed a decrease in VEP amplitude with normal latency in the left eye.

Figure 6

(A) Fundus fluorescein angiogram at presentation of syphilitic papillitis. (B) Fundus fluorescein angiogram 4 weeks after treatment.

On clinical examination, neurological symptoms were excluded. A reactive Treponema pallidum hemagglutination assay (TPHA) with low rapid plasma reagin (RPR) titer was performed. An HIV antibody test gave negative results. Different internal localization of syphilis (gumma) and mucocutaneous lesions were absent. Blood tests to eliminate the suspicion of other infections and systemic disorders were performed. An MRI of the orbits and head with contrast did not show signal alteration.

The patient was treated with 12 million units of aqueous penicillin G intravenously daily (3 million units intravenously every 4 h) for 14 days with resolution of the anterior segment and the optical nerve inflammation. As the antibiotic therapy was administered, the patient's visual acuity gradually fully recovered. He was unfortunately lost to follow up because our hospital accepts and treats patients who have no residence permit and who often are afraid to report for checks.

Conclusions

Papillitis, also known as optic neuritis, is characterized by inflammation and deterioration of the portion of the optic nerve known as the optic disc. This localization is a relatively rare ocular manifestation of syphilis and its incidence is high in HIV-positive individuals [1315].

Uveitis is more common in early syphilis [16] and may be accompanied by neurosyphilis. Among patients with secondary syphilis, about 5% present with chorioretinitis and 50% of these with bilateral lesions [16, 17].

Moreover, granulomatosus anterior uveitis could be related to other infectious diseases and autoimmune disorders (tuberculosis, herpes viruses, Lyme disease, Behçet's disease, sarcoidosis) that have to be excluded.

In our patient's case, the diagnosis of papillitis due to T. pallidum was performed on the basis of serological positive test and clinical ocular manifestations. The consideration that our patient was young and a congenital infection, which can be asymptomatic in 50% of cases and is very rare, could not be excluded (30% to 40% of untreated persons) [18, 19]. Other stages than tertiary syphilis were excluded because genital and mucocutaneous lesions were absent. The debate about performing lumbar puncture on HIV-negative patients with syphilis is still open [20, 21]. The absence of HIV positivity and of neuroradiological alterations and the previous antibiotic treatment allowed us to avoid lumbar puncture. The treatment of papillitis was managed as neurosyphilis [22, 23]. A report on posterior ocular manifestation of syphilis with spontaneous resolution was published recently [24]. Furthermore, experts do not recommend the treatment for neurosyphilis in HIV-negative individuals in whom T. Pallidum is found on CSF without other abnormalities [20]. On the basis of the reported case, we theorized that previous antibiotic therapy for other diseases in patients with syphilis may alter the natural history, the course, and the clinical manifestations of the pathology. In the available medical literature, only a few cases of papillitis due to T. pallidum are described in immunocompetent persons [2528]. No report exists of unilateral papillitis as the first and only manifestation of syphilis in HIV-uninfected migrants. Despite the existence of programs aimed at controlling sexually transmitted diseases in Europe, syphilis screening among migrants is infrequently recommended. In Europe, studies on the seroprevalence of syphilis in migrants are generally conducted on migrant sex workers [29, 30]. In Spain, sex workers from South America with syphilis antibodies were reported in 3% of cases [31]. In 2009, an increase in the incidence of ocular syphilis in homosexual HIV-positive individuals was observed in Italy [32]. In Portugal, where African migrants are prevalent, syphilis is reported in 4.1% of sexually transmitted infections [33].

Syphilitic ocular manifestation should be considered in all patients with or without concurrent HIV infection or in any case of vision loss of uncertain origin with unexplained ocular inflammation. Syphilis screening through ocular examination should be performed to aid in the detection of such cases (among migrants from countries registering high prevalence of this sexually transmitted disease).

Consent

Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.

Declarations

Authors’ Affiliations

(1)
National Institute for Health, Migration and Poverty (INMP/NIHMP)
(2)
Ophthalmological Science Department, University 'La Sapienza'

References

  1. Savage EJ, Hughes G, Ison C, Lowndes CM, European Surveillance of Sexually Transmitted Infections Network: Syphilis and gonorrhoea in men who have sex with men: a European overview. Euro Surveill 2009., 14(47): ppi:19417Google Scholar
  2. Dougan S, Evans BG, Elford J: Sexually transmitted infections in Western Europe among HIV-positive men who have sex with men. Sex Transm Dis 2007, 34: 783–790.PubMedGoogle Scholar
  3. Kuo IC, Kapusta MA, Rao NA: Vitritis as the primary manifestation of ocular syphilis in patients with HIV infection. Am J Ophthalmol 1998, 125: 306–311. 10.1016/S0002-9394(99)80136-6View ArticlePubMedGoogle Scholar
  4. Browning DJ: Posterior segment manifestations of active ocular syphilis, their response to a neurosyphilis regimen of penicillin therapy, and the influence of human immunodeficiencyvirus status on response. Ophthalmology 2000, 107: 2015–2023. 10.1016/S0161-6420(00)00457-7View ArticlePubMedGoogle Scholar
  5. Stolte IG, Dukers NH, de Wit JB, Fennema JS, Coutinho RA: Increase in sexually transmitted infections among homosexual men in Amsterdam in relation to HAART. Sex Transm Infect 2001, 77: 184–186. 10.1136/sti.77.3.184PubMed CentralView ArticlePubMedGoogle Scholar
  6. Marra CM: Update on neurosyphilis. Curr Infect Dis Rep 2009, 11: 127–134. 10.1007/s11908-009-0019-1View ArticlePubMedGoogle Scholar
  7. Ronald AR, Silverman M, McCutchan JA, Corey L, Handsfield HH: Evaluation of new anti-infective drugs for the treatment of syphilis. Infectious Diseases Society of America and the Food and Drug Administration. Clin Infect Dis 1992, 15(Suppl 1):S140–147. S 99–107View ArticlePubMedGoogle Scholar
  8. Chao JR, Khurana RN, Fawzi AA, Reddy HS, Rao NA: Syphilis: re-emergence of an old adversary. Ophthalmology 2006, 113: 2074–2079. 10.1016/j.ophtha.2006.05.048View ArticlePubMedGoogle Scholar
  9. Probst LE, Wilkinson J, Nichols BD: Diagnosis of congenital syphilis in adults presenting with interstitial keratitis. Can J Ophthalmol 1994, 29: 77–80.PubMedGoogle Scholar
  10. Aldave AJ, King JA, Cunningham ET Jr: Ocular syphilis. Curr Opin Ophthalmol 2001, 12: 433–441. 10.1097/00055735-200112000-00008View ArticlePubMedGoogle Scholar
  11. Doris JP, Saha K, Jones NP, Sukthankar A: Ocular syphilis: the new epidemic. Eye 2006, 20: 703–705. 10.1038/sj.eye.6701954View ArticlePubMedGoogle Scholar
  12. Jumper JM, Machemer R, Gallemore RP, Jaffe GJ: Exudative retinal detachment and retinitis associated with acquired syphilitic uveitis. Retina 2000, 20: 190–194. 10.1097/00006982-200002000-00013View ArticlePubMedGoogle Scholar
  13. B'chir Hanzaoui S, Znagui Z, Farah , Bouslama K, Ben Dridi M: A case of papillitis revealing primary syphilis [in French]. Med Mal Infect 2007, 37: 67–68. 10.1016/j.medmal.2006.08.006View ArticleGoogle Scholar
  14. Shalaby IA, Dunn JP, Semba RD, Jabs DA: Syphilitic uveitis in human immunodeficiency virus-infected patients. Arch Ophthalmol 1997, 115: 469–473. 10.1001/archopht.1997.01100150471003View ArticlePubMedGoogle Scholar
  15. Tamesis RR, Foster CS: Ocular syphilis. Ophthalmology 1990, 97: 1281–1287.View ArticlePubMedGoogle Scholar
  16. Kiss S, Damico FM, Young LH: Ocular manifestations and treatment of syphilis. Semin Ophthalmol 2005, 20: 161–167. 10.1080/08820530500232092View ArticlePubMedGoogle Scholar
  17. Morgan S, Laufer H: Atypical syphilitic chorioretinitis and vasculitis. Retina 1984, 4: 225–231. 10.1097/00006982-198400440-00003View ArticlePubMedGoogle Scholar
  18. Saloojee H, Velaphi S, Goga Y, Afadapa N, Steen R, Lincetto O: The prevention and management of congenital syphilis: an overview and recommendations. Bull World Health Organ 2004, 82: 424–430.PubMed CentralPubMedGoogle Scholar
  19. Valderrama J, Zacarias F, Mazin R: Maternal syphilis and congenital syphilis in Latin America: big problem, simple solution [in Spanish]. Rev Panam Salud Publica 2004, 16: 211–217.View ArticlePubMedGoogle Scholar
  20. Marra CM, Maxwell CL, Smith SL, Lukehart SA, Rompalo AM, Eaton M, Stoner BP, Augenbraun M, Barker DE, Corbett JJ, Zajackowski M, Raines C, Nerad J, Kee R, Barnett SH: Cerebrospinal fluid abnormalities in patients with syphilis: association with Clinical and laboratory features. J Infect Dis 2004, 189: 369–376. 10.1086/381227View ArticlePubMedGoogle Scholar
  21. Dans PE, Cafferty L, Otter SE, Johnson RJ: Inappropriate use of the cerebrospinal fluid Venereal Disease Research Laboratory (VDRL) test to exclude neurosyphilis. Ann Intern Med 1986, 104: 86–89.View ArticlePubMedGoogle Scholar
  22. Chao JR, Khurana RN, Fawzi AA, Reddy HS, Rao NA: Syphilis: reemergence of an old adversary. Ophthalmology 2006, 113: 2074–2079. 10.1016/j.ophtha.2006.05.048View ArticlePubMedGoogle Scholar
  23. Hart G: Syphilis tests in diagnostic and therapeutic decision making. Ann Intern Med 1986, 104: 368–376.View ArticlePubMedGoogle Scholar
  24. Chen J, Lee L: Posterior placoid chorioretinitis: An unusual ocular manifestation of syphilis. Clin Opthalmol 2008, 2: 669–673.View ArticleGoogle Scholar
  25. Porstman AU, Marcus U, Pleyer U: Primary diagnosis of syphilis by the ophthalmologist [in German]. Klin Monbl Augenheilkd 2002, 219: 349–352. 10.1055/s-2002-32632View ArticleGoogle Scholar
  26. Ruiz-Veraga Ruiz-Vegara M, Monge-Argilés JA, Turpin-Fenoll L, Marti-Martinez S, Pampliega-Pérez A: Unilateral papillitis as the presenting symptom of neurosyphilis [in Spanish]. Rev Neurol 2008, 46: 188–189.Google Scholar
  27. Bialasiewicz AA, Dommer S: Disseminated choroiditis, papillitis and vasculitis retinae as main findings in lues II-III [in German]. Klin Monbl Augenheilkd 1991, 198: 37–43. 10.1055/s-2008-1045926View ArticlePubMedGoogle Scholar
  28. Dumortier C, Alcaraz I, Tone A, Burban SD, Delesalle F, Maryse F, Melliez H, Viget N, Baclet V, Pavel S, Ajana F, Yazdanpanah Y: Non-cutaneous manifestations of secondary syphilis [in French]. Ann Dermatol Venereol 2008, 135: 451–458. 10.1016/j.annder.2008.03.022View ArticlePubMedGoogle Scholar
  29. Amirkhanian YA, Kelly JA, Kirsanova AV, DiFranceisco W, Khoursine RA, Semenov AV, Rozmanova VN: HIV risk behaviour patterns, predictors, and sexually transmitted disease prevalence in the social networks of young men who have sex with men in St Petersburg Russia. Int J STD AIDS 2006, 17: 50–56. 10.1258/095646206775220504PubMed CentralView ArticlePubMedGoogle Scholar
  30. Burns FM, Mercer CH, Evans AR, Gerry CJ, Mole R, Hart GJ: Increased attendances of people of eastern European origin at sexual health services in London. Sex Transm Infect 2009, 85: 75–78. 10.1136/sti.2007.029546View ArticlePubMedGoogle Scholar
  31. Gutiérrez M, Tajada P, Alvarez A, De Juliàn R, Baquero M, Soriano V, Holguin A: Prevalence of HIV-1 non-B subtypes, syphilis, HTLV, and hepatitis B and C viruses among immigrant sex workers in Madrid, Spain. J Med Virol 2004, 74: 521–527. 10.1002/jmv.20208View ArticlePubMedGoogle Scholar
  32. Fonollosa A, Giralt J, Pelegrín L, Sánchez-Dalmau B, Segura A, Adan A: Ocular syphilis back again: understanding recent increases in the incidence of ocular syphilitic disease. Ocul Immunol Inflamm 2009, 17: 207–212. 10.1080/09273940902741709View ArticlePubMedGoogle Scholar
  33. Tavora-Tavira L, Teodosio R, Seixas J, Prieto E, Castro R, Exposto F, Atouguia J: Sexually transmitted infections in an African migrant population in Portugal: a base-line study. J Infect Dev Ctries 2007, 1: 326–328. 10.1136/sti.2007.029546PubMedGoogle Scholar

Copyright

© Turchetti et al; licensee BioMed Central Ltd. 2012

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Advertisement